Investigation into the efficacy and safety profile of oral small-molecule GLP-1 receptor agonists in type 2 diabetes and obesity: a systematic review and meta-analysis - Poll - MDSpire

Investigation into the efficacy and safety profile of oral small-molecule GLP-1 receptor agonists in type 2 diabetes and obesity: a systematic review and meta-analysis

  • By

  • Li Li

  • Dianpeng Shui

  • Xiong Zhang

  • Bing Tan

  • Yan Deng

  • July 7, 2026

  • 0 min

Share

Original Source(s)

Investigation into the efficacy and safety profile of oral small-molecule GLP-1 receptor agonists in type 2 diabetes and obesity: a systematic review and meta-analysis

  • by Li Li, Dianpeng Shui, Xiong Zhang, Bing Tan, Yan Deng

  • July 7, 2026

Related Content

Immunometabolic interactions in individuals with down syndrome across childhood, adolescence and adulthood in relation to their siblings

Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study

Reduced circulating mitochondrial DNA integrity and increased DNA oxidation in preclinical and clinical pediatric obesity: an observational study